A bioethicist and a professor of medicine on regulating AI in health care
Effy Vayena and Andrew Morris offer three approaches
THE ARTIFICIAL INTELLIGENCE (AI) sensation ChatGPT, and rivals such as BLOOM and Stable Diffusion, are large language models for consumers. ChatGPT has caused particular delight since it first appeared in November. But more specialised AI is already used widely in medical settings, including in radiology, cardiology and ophthalmology. Major developments are in the pipeline. Med-PaLM, developed by DeepMind, the AI firm owned by Alphabet, is another large language model. Its 540bn parameters have been trained on data sets spanning professional medical exams, medical research and consumer health-care queries. Such technology means our societies now need to consider the best ways for doctors and AI to best work together, and how medical roles will change as a consequence.
Explore more
Discover more
America’s debt cannot keep stacking up, says Jeffrey Gundlach
The “King of Bonds” sees the risk of a debt restructuring with global repercussions
South Korea’s crisis highlights both fragility and resilience, writes Wi Sung-lac
The country is deeply polarised, but its living memory of military rule strengthens its commitment to democracy
How to turn European savings into investment, innovation and growth, by Christine Lagarde
A fragmented financial infrastructure means that Europe gets less bang for its euro
An agenda to maximise AI’s benefits and minimise harms, by David Patterson
How technologists, researchers and policymakers can reassure people AI will serve the public good
A broader peace is within Israel’s grasp, say Tamir Pardo and Nimrod Novik
A former Mossad director and former foreign-policy adviser on an offer not to be refused
Three presidents on the partnerships that can at last transform Africa
Success teeters on bold, stable funding, say Julius Maada Bio, Lazarus Chakwera and Andry Rajoelina